PEAK6 Investments’s Arcus Biosciences RCUS Stock Holding History

PEAK6 Investments’s Portfolio RCUS Stock Details RCUS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-25,000	Closed	-$381K	–	3982
2024 Q2	$381K	Hold	25,000	–	–	﹤0.01%	2400
2024 Q1	$472K	Buy	+25,000	New	+$432K	﹤0.01%	2488
2023 Q1	–	Sell	-18,100	Closed	-$374K	–	4842
2022 Q4	$374K	Buy	+18,100	New	+$498K	﹤0.01%	2763

Other funds holding RCUS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PEAK6 Investments's RCUS Position: Q3 2024 in Review

PEAK6 Investments opened a new position in Arcus Biosciences (RCUS) in Q3 2024: 15,000 shares worth $229K. The stake represents ﹤0.01% of the portfolio and ranks #2716 among its holdings.

187 funds tracked by Wall St. Rank hold RCUS as of Q3 2024.

PEAK6 Investments held 15,000 shares of Arcus Biosciences worth $229K as of Q3 2024.
Arcus Biosciences was a new PEAK6 Investments position in Q3 2024.
Arcus Biosciences made up ﹤0.01% of PEAK6 Investments's portfolio in Q3 2024, its #2716 holding.
187 funds tracked by Wall St. Rank held Arcus Biosciences as of Q3 2024.

Based on PEAK6 Investments's 13F filing for Q3 2024, filed 14 Nov 2024.